Skip to main content
. 2019 Jan 8;2019(1):CD006404. doi: 10.1002/14651858.CD006404.pub3

3.6. Analysis.

Comparison 3 Pyronaridine‐artesunate versus mefloquine plus artesunate, Outcome 6 Adverse events leading to withdrawal.